Clinical Trial Update: GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating GW640385 in combination with ritonavir and nucleoside reverse transcriptase inhibitors (NRTIs) …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GW640385
• NRTIs
• Ritonavir (Ritonavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I, HIV Infection | Phase 2 | Status: COMPLETED